Webinar

What is the clinical impact of brain atrophy?

For the nordic and baltic countries
Time: 27th of may 2019, 15.30-16.00 CET

There is an increased focus on the importance of preserving the brain in the MS community. Early initiation of treatments that control the inflammatory process and reduce the overall rate of brain volume loss is at the core of these discussions. Prof Alex Rovira will will discuss the clinical impact of brain atrophy in MS and how global brain volume loss is associated with and predicts disability in all clinical MS phenotypes.

Listen in and have the opportunity to ask questions and have peer-to-peer exchange with a top international MS expert!

Speaker

Prof. Alex Rovira, Barcelona, Spain

RegisterRegister 

Register for the event here 

 

Participate

Participate

Using your PC/MAC, tablet or even smartphone

 

Connect

Connect

Connect and engage with peers across and get the possibility to discuss with a top international KOL!

Mötet följer de regler som gäller enligt avtalet mellan LIF och Sveriges Kommuner och Landsting. Inbjudan är skickad till verksamhetschefer med kopia till läkare och sjuksköterskor med intresse av MS.

Speaker Dr. Rovira

Dr. Rovira is Director of the Magnetic Resonance Unit, and of the Section of Neuroradiology at University Hospital Vall d’Hebron, Barcelona, Spain. He is also Professor of Radiology and Neuroimmunology at the Autonomous University of Barcelona. 

He is specialised in diagnostic neuroradiology, and head and neck radiology, with particular interest in demyelinating diseases, stroke, neuro-oncology, hepatic encephalopathy, and head and necktumours.

He is currently Past-President of the European Society of Neuroradiology, member of MAGNIMS (European Multicenter Collaborative Research Network on MRI
in MS), of the Executive Committee of the Spanish Society of Radiology, and of the World Federation of Neuroradiological Societies. He is on the editorial
boards of the American Journal of Neuroradiology, Neuroradiology and MS Forum, and member of the International Advisory Board on Clinical Trials in MS.

Moderator Dr. Øivind Torkildsen 

Dr. Øivind Torkildsen is a Consultant Neurologist and Professor of Neurology at the Norwegian Multiple Sclerosis Competence Centre, at Haukeland University Hospital, Bergen in Norway.

He has a long research experience in both clinical and preclinical studies and has coordinated a number of clinical trials. He is a member of the Norwegian Medical Association and Norwegian Neurological Association. His current research focuses on the etiology and treatment of the disease.

Torkildsen has authored more than 80 peer reviewed publications. He has a long experience in the treatment of multiple sclerosis patients.

GZSE.MS.19.04.0100, Maj 2019